Step Into the Future of Precision Health Screening and join us at ECR 2024Book a meeting
Artificial intelligence” (Quantib® Prostate) to improve cancer detection in transperineal MRI/ultrasound fusion biopsies of the prostate – The next game changer?
DGU CONFERENCE PRESENTATION, 2022
K.Günzel, C. A. Hamm, J. Schlegel, S. Heinrich, H. Cash, J. Busch, S. Hinz, B. Hamm, A. Magheli
August 19, 2022
This prospective analysis evaluates the detection and localization of PCa by Quantib in 150 patients when performing transperineal mRI/ultrasound fusion biopsies of the prostate.
The use of AI software to evaluate mpMRI before MRI-TRUS-TPBx could improve PCa detection and localization. The Urologist using Quantib detected all clinically relevant PI-RADS index lesions, and 10 PCa not detected by initial radiology reading without AI software.
This collected information is necessary to provide you with the critical features available on our Website. Because this information is essential to your experience, you are unable to alter these settings and still use the Website.
This information is used to enhance your experience on our Website. If we are unable to collect this important yet non-essential information, certain functions and items will not be available or work as intended.